Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harvard Bioscience (NQ: HBIO )

3.560 -0.120 (-3.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115,411
Open 3.700
Bid (Size) 3.500 (8)
Ask (Size) 4.250 (20)
Prev. Close 3.680
Today's Range 3.530 - 3.825
52wk Range 3.440 - 6.200
Shares Outstanding 42,688,246
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024
HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Harvard Bioscience Announces First Quarter 2024 Financial Results
Strong gross margin performance and focus on efficiency to support ongoing investments in growth 
From Harvard Bioscience, Inc.
Via GlobeNewswire

Performance

YTD
-33.95%
-33.95%
1 Month
-23.28%
-23.28%
3 Month
-23.77%
-23.77%
6 Month
-13.17%
-13.17%
1 Year
-36.31%
-36.31%

More News

Read More
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
A Preview Of Harvard Bioscience's Earnings
Via Benzinga
Earnings Preview For Harvard Bioscience
Via Benzinga
Preview: Harvard Bioscience's Earnings
Via Benzinga
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
From Harvard Bioscience, Inc.
Via GlobeNewswire
Earnings Scheduled For March 7, 2024
Via Benzinga
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Third Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
From Harvard Bioscience, Inc.; Etisense
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Harvard Bioscience Announces Second Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
From Harvard Bioscience, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.